<p>Thrivent Financial for Lutherans 在最近向证券交易委员会（SEC）提交的文件中表示，在第二季度减少了对 Chemed Corporation（纽约证券交易所代码：CHE - 免费报告）股票的持仓，降幅为 4.8%。该基金在此期间出售了 4,516 股后，持有该公司 90,213 股股票。Thrivent Financial for Lutherans 在最近的报告期末持有 Chemed 0.62% 的股份，价值 43,928,000 美元。</p>
<ul>
<li>3 适应经济衰退的股票，在经济低迷时表现良好</li>
</ul>
<p>其他机构投资者和对冲基金最近也对该公司的持仓进行了调整。Creekmur Asset Management LLC 在第二季度购买了价值约 28,000 美元的 Chemed 新股份。SVB Wealth LLC 在第一季度购买了价值约 30,000 美元的 Chemed 新股份。WPG Advisers LLC 在第一季度购买了价值约 32,000 美元的 Chemed 新股份。Parkside Financial Bank &amp; Trust 在第二季度将其在 Chemed 的持仓增加了 86.3%。Parkside Financial Bank &amp; Trust 现在持有 95 股该公司股票，价值 46,000 美元，此前在此期间又购买了 44 股。最后，Geneos Wealth Management Inc. 在第一季度将其在 Chemed 的持仓提升了 330.4%。Geneos Wealth Management Inc. 现在持有 99 股该公司股票，价值 61,000 美元，此前在上个季度又购买了 76 股。机构投资者目前持有该公司 95.85% 的股票。</p>
<h2>Chemed 的内部买卖</h2>
<p>在其他消息中，首席执行官 Kevin J. Mcnamara 于 11 月 24 日星期一出售了 2,000 股 Chemed 股票。股票以平均价格 437.55 美元出售，总交易额为 875,100.00 美元。出售完成后，首席执行官直接持有该公司 94,197 股股票，价值约 41,215,897.35 美元。此次交易使其持仓减少了 2.08%。该交易已在向 SEC 提交的法律文件中披露，相关文件可通过此链接访问。公司内部人士持有该公司 3.29% 的股票。</p>
<h2>Chemed 股票表现</h2>
<p>CHE 股票在周二开盘价为 430.15 美元。该公司的市值为 60.9 亿美元，市盈率为 22.75，市盈增长比率为 2.40，贝塔值为 0.46。Chemed Corporation 的 52 周低点为 408.42 美元，52 周高点为 623.60 美元。该公司的 50 日移动平均线为 435.66 美元，200 日移动平均线为 462.14 美元。</p>
<p>Chemed（纽约证券交易所代码：CHE - 获取免费报告）最近于 10 月 28 日星期二公布了其财报。该公司报告季度每股收益为 5.27 美元，低于分析师一致预期的 5.39 美元，差额为 0.12 美元。Chemed 的股本回报率为 25.89%，净利润率为 11.02%。该季度的营业收入为 6.249 亿美元，而一致预期为 6.2604 亿美元。去年同期，该公司每股收益为 5.64 美元。与去年同期相比，Chemed 的收入增长了 3.1%。Chemed 已设定 2025 财年的每股收益指导范围为 22.000-22.300。根据分析师的平均预测，Chemed Corporation 本财年的每股收益预计为 21.43。</p>
<h2>Chemed 宣布分红</h2>
<p>该公司最近还宣布了一项季度分红，该分红于 12 月 5 日星期五支付。11 月 17 日星期一的股东获得了 0.60 美元的分红。该分红的除息日为 11 月 17 日星期一。这相当于每年 2.40 美元的分红，分红收益率为 0.6%。Chemed 的分红支付比率目前为 12.69%。</p>
<h2>华尔街分析师预测增长</h2>
<p>一些研究分析师最近对该股票发表了看法。加拿大皇家银行在 11 月 10 日星期一的研究报告中将 Chemed 的目标价格从 589.00 美元下调至 572.00 美元，并对该公司给予了 “跑赢大盘” 的评级。美国银行在 9 月 10 日星期三的报告中将 Chemed 的目标价格从 610.00 美元下调至 595.00 美元，并对该公司给予了 “买入” 评级。Jefferies Financial Group 在 9 月 2 日星期二的研究报告中将 Chemed 的评级从 “持有” 上调至 “买入”，并将该公司的目标价格从 490.00 美元上调至 550.00 美元。Zacks Research 在 10 月 30 日星期四的报告中将 Chemed 的评级从 “强烈卖出” 上调至 “持有”。最后，Weiss Ratings 在 10 月 8 日星期三的研究报告中重申了对 Chemed 股票的 “持有（c-）” 评级。四位股票研究分析师对该股票给予了 “买入” 评级，两位分析师给予了 “持有” 评级。根据 MarketBeat.com 的数据，Chemed 目前的平均评级为 “适度买入”，平均目标价格为 574.25 美元。</p>
<p><strong>查看我们关于 CHE 的最新报告</strong></p>
<h2>Chemed 公司简介</h2>
<p>（免费报告）</p>
<p>Chemed Corporation 通过一网络的医生、注册护士、家庭健康助手、社会工作者、牧师和志愿者，主要在美国为患者提供临终关怀和缓和医疗服务。该公司在 VITAS 和 Roto-Rooter 两个部门运营。它通过公司拥有的分支机构、独立承包商和特许经营商，向住宅和商业客户提供管道、排水清洁、挖掘、水恢复和其他相关服务。</p>
<h2>另请参阅</h2>
<ul>
<li>五只我们更看好的股票，胜过 Chemed</li>
<li>什么是 MarketRank™？如何使用它</li>
<li>ServiceNow 的 70 亿美元赌注：恐慌还是机会？</li>
<li>成长股：它们是什么，它们又不是？</li>
<li>戴尔和惠普正在涨价——投资者应注意</li>
<li>多元化可以平滑回报并降低投资组合风险</li>
<li>为什么 DLocal 是 2026 年值得关注的顶级新兴市场金融科技股票</li>
</ul>
<p><strong>想看看其他对冲基金持有的 CHE 股票吗？</strong> 访问 HoldingsChannel.com 获取 Chemed Corporation（纽约证券交易所代码：CHE - 免费报告）的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNIRQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNIRQ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1000 美元在 Chemed 吗？</h2>
<p>在考虑 Chemed 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Chemed 并不在名单上。</p>
<p>虽然 Chemed 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>Thrivent Financial for Lutherans 在第二季度减少了对 Chemed Corporation 的持股比例 4.8%，目前持有 90,213 股，价值 4393 万美元。其他机构投资者也调整了他们的持仓。Chemed 的首席执行官出售了 2,000 股。该公司第三季度的收益未达到预期，收入同比增长 3.1%。Chemed 宣布每季度派发 0.60 美元的股息。分析师的评级意见不一，既有下调也有上调</p>

<p>Thrivent Financial for Lutherans lessened its position in shares of Chemed Corporation (NYSE:CHE - Free Report) by 4.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 90,213 shares of the company's stock after selling 4,516 shares during the period. Thrivent Financial for Lutherans owned 0.62% of Chemed worth $43,928,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>Thrivent Financial for Lutherans 在最近向证券交易委员会（SEC）提交的文件中表示，在第二季度减少了对 Chemed Corporation（纽约证券交易所代码：CHE - 免费报告）股票的持仓，降幅为 4.8%。该基金在此期间出售了 4,516 股后，持有该公司 90,213 股股票。Thrivent Financial for Lutherans 在最近的报告期末持有 Chemed 0.62% 的股份，价值 43,928,000 美元。</p>
</div><ul>
<li>3 Recession-Ready Stocks That Thrive When the Economy Sputters</li>
</ul>
<div class="lb-trans"><ul>
<li>3 适应经济衰退的股票，在经济低迷时表现良好</li>
</ul>
</div><p>Other institutional investors and hedge funds also recently made changes to their positions in the company. Creekmur Asset Management LLC bought a new stake in Chemed in the 2nd quarter valued at about $28,000. SVB Wealth LLC purchased a new position in shares of Chemed in the first quarter worth about $30,000. WPG Advisers LLC bought a new stake in shares of Chemed in the first quarter valued at approximately $32,000. Parkside Financial Bank &amp; Trust raised its position in shares of Chemed by 86.3% in the second quarter. Parkside Financial Bank &amp; Trust now owns 95 shares of the company's stock valued at $46,000 after purchasing an additional 44 shares during the period. Finally, Geneos Wealth Management Inc. lifted its stake in shares of Chemed by 330.4% during the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company's stock valued at $61,000 after buying an additional 76 shares in the last quarter. Institutional investors own 95.85% of the company's stock.</p>
<div class="lb-trans"><p>其他机构投资者和对冲基金最近也对该公司的持仓进行了调整。Creekmur Asset Management LLC 在第二季度购买了价值约 28,000 美元的 Chemed 新股份。SVB Wealth LLC 在第一季度购买了价值约 30,000 美元的 Chemed 新股份。WPG Advisers LLC 在第一季度购买了价值约 32,000 美元的 Chemed 新股份。Parkside Financial Bank &amp; Trust 在第二季度将其在 Chemed 的持仓增加了 86.3%。Parkside Financial Bank &amp; Trust 现在持有 95 股该公司股票，价值 46,000 美元，此前在此期间又购买了 44 股。最后，Geneos Wealth Management Inc. 在第一季度将其在 Chemed 的持仓提升了 330.4%。Geneos Wealth Management Inc. 现在持有 99 股该公司股票，价值 61,000 美元，此前在上个季度又购买了 76 股。机构投资者目前持有该公司 95.85% 的股票。</p>
</div><h2>Insider Buying and Selling at Chemed</h2>
<div class="lb-trans"><h2>Chemed 的内部买卖</h2>
</div><p>In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Monday, November 24th. The shares were sold at an average price of $437.55, for a total transaction of $875,100.00. Following the completion of the sale, the chief executive officer directly owned 94,197 shares of the company's stock, valued at approximately $41,215,897.35. The trade was a 2.08% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 3.29% of the company's stock.</p>
<div class="lb-trans"><p>在其他消息中，首席执行官 Kevin J. Mcnamara 于 11 月 24 日星期一出售了 2,000 股 Chemed 股票。股票以平均价格 437.55 美元出售，总交易额为 875,100.00 美元。出售完成后，首席执行官直接持有该公司 94,197 股股票，价值约 41,215,897.35 美元。此次交易使其持仓减少了 2.08%。该交易已在向 SEC 提交的法律文件中披露，相关文件可通过此链接访问。公司内部人士持有该公司 3.29% 的股票。</p>
</div><h2>Chemed Stock Performance</h2>
<div class="lb-trans"><h2>Chemed 股票表现</h2>
</div><p>Shares of CHE stock opened at $430.15 on Tuesday. The company has a market capitalization of $6.09 billion, a PE ratio of 22.75, a price-to-earnings-growth ratio of 2.40 and a beta of 0.46. Chemed Corporation has a 52-week low of $408.42 and a 52-week high of $623.60. The business's fifty day moving average is $435.66 and its 200 day moving average is $462.14.</p>
<div class="lb-trans"><p>CHE 股票在周二开盘价为 430.15 美元。该公司的市值为 60.9 亿美元，市盈率为 22.75，市盈增长比率为 2.40，贝塔值为 0.46。Chemed Corporation 的 52 周低点为 408.42 美元，52 周高点为 623.60 美元。该公司的 50 日移动平均线为 435.66 美元，200 日移动平均线为 462.14 美元。</p>
</div><p>Chemed (NYSE:CHE - Get Free Report) last announced its earnings results on Tuesday, October 28th. The company reported $5.27 earnings per share for the quarter, missing analysts' consensus estimates of $5.39 by ($0.12). Chemed had a return on equity of 25.89% and a net margin of 11.02%.The business had revenue of $624.90 million during the quarter, compared to the consensus estimate of $626.04 million. During the same quarter in the prior year, the company earned $5.64 earnings per share. Chemed's revenue was up 3.1% compared to the same quarter last year. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. On average, sell-side analysts forecast that Chemed Corporation will post 21.43 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Chemed（纽约证券交易所代码：CHE - 获取免费报告）最近于 10 月 28 日星期二公布了其财报。该公司报告季度每股收益为 5.27 美元，低于分析师一致预期的 5.39 美元，差额为 0.12 美元。Chemed 的股本回报率为 25.89%，净利润率为 11.02%。该季度的营业收入为 6.249 亿美元，而一致预期为 6.2604 亿美元。去年同期，该公司每股收益为 5.64 美元。与去年同期相比，Chemed 的收入增长了 3.1%。Chemed 已设定 2025 财年的每股收益指导范围为 22.000-22.300。根据分析师的平均预测，Chemed Corporation 本财年的每股收益预计为 21.43。</p>
</div><h2>Chemed Announces Dividend</h2>
<div class="lb-trans"><h2>Chemed 宣布分红</h2>
</div><p>The business also recently declared a quarterly dividend, which was paid on Friday, December 5th. Stockholders of record on Monday, November 17th were issued a $0.60 dividend. The ex-dividend date of this dividend was Monday, November 17th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.6%. Chemed's dividend payout ratio is presently 12.69%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度分红，该分红于 12 月 5 日星期五支付。11 月 17 日星期一的股东获得了 0.60 美元的分红。该分红的除息日为 11 月 17 日星期一。这相当于每年 2.40 美元的分红，分红收益率为 0.6%。Chemed 的分红支付比率目前为 12.69%。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>A number of research analysts recently weighed in on the stock. Royal Bank Of Canada reduced their price objective on shares of Chemed from $589.00 to $572.00 and set an &#34;outperform&#34; rating for the company in a research note on Monday, November 10th. Bank of America cut their price target on Chemed from $610.00 to $595.00 and set a &#34;buy&#34; rating for the company in a report on Wednesday, September 10th. Jefferies Financial Group upgraded Chemed from a &#34;hold&#34; rating to a &#34;buy&#34; rating and lifted their price target for the company from $490.00 to $550.00 in a research report on Tuesday, September 2nd. Zacks Research raised Chemed from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a report on Thursday, October 30th. Finally, Weiss Ratings restated a &#34;hold (c-)&#34; rating on shares of Chemed in a research note on Wednesday, October 8th. Four equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. Based on data from MarketBeat.com, Chemed presently has an average rating of &#34;Moderate Buy&#34; and an average price target of $574.25.</p>
<div class="lb-trans"><p>一些研究分析师最近对该股票发表了看法。加拿大皇家银行在 11 月 10 日星期一的研究报告中将 Chemed 的目标价格从 589.00 美元下调至 572.00 美元，并对该公司给予了 “跑赢大盘” 的评级。美国银行在 9 月 10 日星期三的报告中将 Chemed 的目标价格从 610.00 美元下调至 595.00 美元，并对该公司给予了 “买入” 评级。Jefferies Financial Group 在 9 月 2 日星期二的研究报告中将 Chemed 的评级从 “持有” 上调至 “买入”，并将该公司的目标价格从 490.00 美元上调至 550.00 美元。Zacks Research 在 10 月 30 日星期四的报告中将 Chemed 的评级从 “强烈卖出” 上调至 “持有”。最后，Weiss Ratings 在 10 月 8 日星期三的研究报告中重申了对 Chemed 股票的 “持有（c-）” 评级。四位股票研究分析师对该股票给予了 “买入” 评级，两位分析师给予了 “持有” 评级。根据 MarketBeat.com 的数据，Chemed 目前的平均评级为 “适度买入”，平均目标价格为 574.25 美元。</p>
</div><p><strong>View Our Latest Report on CHE</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 CHE 的最新报告</strong></p>
</div><h2>Chemed Profile</h2>
<div class="lb-trans"><h2>Chemed 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.</p>
<div class="lb-trans"><p>Chemed Corporation 通过一网络的医生、注册护士、家庭健康助手、社会工作者、牧师和志愿者，主要在美国为患者提供临终关怀和缓和医疗服务。该公司在 VITAS 和 Roto-Rooter 两个部门运营。它通过公司拥有的分支机构、独立承包商和特许经营商，向住宅和商业客户提供管道、排水清洁、挖掘、水恢复和其他相关服务。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另请参阅</h2>
</div><ul>
<li>Five stocks we like better than Chemed</li>
<li>What is MarketRank™? How to Use it</li>
<li>ServiceNow’s $7 Billion Gamble: Panic or Opportunity?</li>
<li>Growth Stocks: What They Are, What They Are Not</li>
<li>Dell and HP Are Raising Prices—And Investors Should Take Note</li>
<li>Diversification Can Smooth Returns And Mitigate Portfolio Risk</li>
<li>Why DLocal Is the Top Emerging Market Fintech Stock to Watch for 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Chemed</li>
<li>什么是 MarketRank™？如何使用它</li>
<li>ServiceNow 的 70 亿美元赌注：恐慌还是机会？</li>
<li>成长股：它们是什么，它们又不是？</li>
<li>戴尔和惠普正在涨价——投资者应注意</li>
<li>多元化可以平滑回报并降低投资组合风险</li>
<li>为什么 DLocal 是 2026 年值得关注的顶级新兴市场金融科技股票</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding CHE?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对冲基金持有的 CHE 股票吗？</strong> 访问 HoldingsChannel.com 获取 Chemed Corporation（纽约证券交易所代码：CHE - 免费报告）的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNIRQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=CHE"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Chemed Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Chemed 吗？</h2>
</div><p>Before you consider Chemed, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Chemed 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Chemed 并不在名单上。</p>
</div><p>While Chemed currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Chemed 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

路德会的 Thrivent Financial 减少了在 Chemed 公司的股票持仓